The Stanford Egg Freezing Study
1 other identifier
interventional
168
1 country
1
Brief Summary
The purpose of this study is to see if the investigators can obtain non-inferior clinical outcomes (similar numbers of oocytes) using the Cardinal protocol, a cost-conscious, low-intensity egg freezing protocol, compared to other routinely used high-intensity clinic protocols. This is a new program for Stanford's Fertility Clinic, so the investigators are assessing patient experience and cost-benefit of a low-cost, low-intensity approach that has demonstrated non-inferiority in IVF for infertility treatment, but has not been similarly evaluated in egg freezing. All enrolled participants will choose the Cardinal protocol or the routine high-intensity protocol designated by their physician. The investigators will then assess number of eggs retrieved, as well as patient satisfaction, cost, and time needed off work to complete the egg freezing cycle. The study's findings could ultimately open the door to implementation of lower-cost standardized protocols that would be more affordable and accessible to people who may otherwise not be able to pursue fertility preservation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 6, 2023
CompletedFirst Posted
Study publicly available on registry
May 3, 2023
CompletedStudy Start
First participant enrolled
July 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 4, 2025
CompletedJanuary 20, 2026
January 1, 2026
1.5 years
April 6, 2023
January 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Mature oocytes cryopreserved per egg freezing cycle
Number of mature oocytes cryopreserved
Identified within 24-48 hours of the oocyte retreival
Oocyte yield per retrieval or egg freezing cycle
Number of oocytes retrieved
Identified within 24 hours of the oocyte retreival
Secondary Outcomes (4)
Participant satisfaction with egg freezing experience and specific protocol (assessed using the Likert scale)
Identified on post-cycle survey completed 1-2 months following oocyte retrieval
Out-of-pocket costs of the egg freezing cycle for the participant
Identified on post-cycle survey completed 1-2 months following oocyte retrieval and via the electronic medical record
Time off-work needed to complete the egg freezing cycle
Identified on post-cycle survey completed 1-2 months following oocyte retrieval
Additional cost per additional oocytes retrieved
Identified from post-cycle survey completed 1-2 months following oocyte retrieval
Study Arms (2)
Low-Intensity Protocol
EXPERIMENTALParticipants choose the low-cost, low-intensity egg-freezing protocol
High-intensity protocol
ACTIVE COMPARATORParticipants choose a routine high-intensity egg-freezing protocol
Interventions
The low-intensity egg freezing protocol involves fewer ultrasounds, bloodwork and injections, contributing to a lower cost. Otherwise, this protocol does not differ significantly from the other routine high-intensity clinic protocols.
The high-intensity egg freezing protocol is a routinely used clinic protocol where patients are coming for frequent ultrasounds and bloodwork, as well as more injections, contributing to a higher overall cost for egg-freezing.
Eligibility Criteria
You may qualify if:
- Ovary-bearing individuals of reproductive age 18-40, interested in pursuing OC
- AMH \> 0.3 ng/mL
- AMH \< 7 ng/mL
You may not qualify if:
- AMH \> 7 ng/mL or physician concern for risk of developing severe OHSS
- History of severe OHSS
- Severe diminished ovarian reserve (DOR) def. as AMH \< 0.3 ng/mL or FSH \> 15
- BMI \> 45
- Any contraindications to ovarian stimulation or outpatient egg retrieval under anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Fertility and Reproductive Health Services
Sunnyvale, California, 94087, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ruth Lathi, MD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Obstetrics & Gynecology
Study Record Dates
First Submitted
April 6, 2023
First Posted
May 3, 2023
Study Start
July 26, 2023
Primary Completion
January 31, 2025
Study Completion
April 4, 2025
Last Updated
January 20, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share